
Oxol 50mg Injection
Marketer
Venus Remedies Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Oxol 50mg Injection
Colon and rectal cancer is treated with Oncoject 50mg, an injectable medication. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition, potentially adjusting over time. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, tiredness, vomiting, and diarrhea. A reduction in blood cell counts (red and white) increasing infection risk is possible. Serious allergic reactions, indicated by symptoms like mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitoring blood cell levels, heart, liver function, and uric acid are essential. Prior to treatment, disclose any existing heart, liver, or kidney conditions, or concurrent use of infection-fighting drugs. Interactions with other medications are possible; inform your healthcare provider of all medications. This medication is contraindicated during pregnancy or breastfeeding. Male infertility is a potential side effect, warranting consultation with a doctor regarding sperm preservation prior to treatment. Post-injection dizziness may impair driving ability.
Uses of Oxol 50mg Injection
Colorectal cancer
Major Benefits of Oxol 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Oxol 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxol 50mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Oxol 50mg Injection works:
The injectable formulation of Oxol, at a 50mg dose, is a cancer therapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxol 50mg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxol 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Oxol 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Oxol 50mg Injection or undergoing Oxaliplatin treatment might induce adverse reactions, including dizziness, nausea, vomiting, and other neurological effects impacting gait. These side effects could impair driving ability.
KidneyCAUTION
Caution is advised when administering Oxol 50mg Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Oxol 50mg Injection use in such patients is limited. Dosage alteration is not suggested for those with mild or moderate kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Oxol 50mg Injection cautiously, as dose modification may be necessary. A physician's consultation is advised.
What if you forget to take Oxol 50mg Injection :
Omit a dose of Oxol 50mg Injection? Seek your physician's advice.
Facts to Know About Oxol 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Platinum-based Anticancer Agents |
